Literature DB >> 1572959

Interpretive criteria for disk diffusion tests using 5-microgram cefdinir disks with rapidly growing clinical isolates.

R N Jones1, M E Erwin, B B Gooding.   

Abstract

Preliminary interpretive zone diameter criteria were calculated for the 5-micrograms cefdinir disk diffusion test by using two potential MIC breakpoints (less than or equal to 0.5 and less than or equal to 1 micrograms/ml). The absolute agreement between tests ranged from 85.9 to 92.4%, and the false-susceptibility errors were principally contributed by the Enterobacter spp. (2.2% error). One proposed criterion was greater than or equal to 20-mm zone diameter (less than or equal to 1 micrograms/ml) for susceptibility and less than or equal to 16-mm zone diameter (greater than 2 micrograms/ml) for resistance to cefdinir. Clinical laboratory users of the disk diffusion method should be cautioned about the possibility of very major interpretive errors among enterobacter isolates.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1572959      PMCID: PMC265208          DOI: 10.1128/jcm.30.4.1022-1023.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests.

Authors:  R N Jones; A L Barry
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

2.  In vitro antibacterial activity of FK482, a new orally active cephalosporin.

Authors:  Y Mine; T Kamimura; Y Watanabe; S Tawara; Y Matsumoto; F Shibayama; H Kikuchi; T Takaya; S Kuwahara
Journal:  J Antibiot (Tokyo)       Date:  1988-12       Impact factor: 2.649

3.  In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). A novel orally administered cephalosporin.

Authors:  B M Briggs; R N Jones; M E Erwin; M S Barrett; D M Johnson
Journal:  Diagn Microbiol Infect Dis       Date:  1991 Sep-Oct       Impact factor: 2.803

4.  Cefixime disk susceptibility test criteria.

Authors:  P C Fuchs; A L Barry; R N Jones
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

5.  Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephem.

Authors:  R N Jones; A L Barry
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

6.  Pharmacokinetics of FK482, a new orally active cephalosporin, in animals.

Authors:  H Sakamoto; T Hirose; S Nakamoto; K Hatano; F Shibayama; H Kikuchi; Y Mine; S Kuwahara
Journal:  J Antibiot (Tokyo)       Date:  1988-12       Impact factor: 2.649

  6 in total
  3 in total

1.  Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia.

Authors:  M Drehobl; P Bianchi; C H Keyserling; K J Tack; T J Griffin
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

2.  Effects of blood medium supplements on activities of newer cephalosporins tested against enterococci.

Authors:  B J Buschelman; R N Jones; M J Bale
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

3.  Interpretive accuracy of the disk diffusion method for testing newer orally administered cephalosporins against Morganella morganii.

Authors:  D J Biedenbach; R N Jones; M E Erwin
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.